Novel small molecule inhibitors show promising efficacy in endometrial cancer, with ongoing trials expanding treatment ...

Two commercialized hematology products, Olverembatinib and Lisaftoclax, drive dual-engine growth with strong China market presenceNext-generation ...

Real-world data reinforces the efficacy and tolerability of lenvatinib and pembrolizumab for treating recurring endometrial cancer.

The FDA is expected to decide on treatments for allergic fungal rhinosinusitis, bipolar I disorder, Hunter syndrome, Leber hereditary optic neuropathy, ovarian cancer, and schizophrenia.

Acrivon Therapeutics shares new trial data showing strong cancer responses, early tumor shrinkage, and pipeline progress, ...

Alix Earle's mom Alisa Earle, who recently underwent an operation, was diagnosed with breast cancer. The TikToker shared the ...

Exploring the role of FXYD family (FXYD domain-containing ion transport regulators) proteins in health and disease The FXYD ...

A look at Exact Sciences Corporation’s acquisition by Abbott: review EXAS revenue growth, margins, and CRC/MRD screening ...

Industry star Marisa Abela shared an encouraging health update nearly six years after being diagnosed with thyroid cancer at ...

Chronic inflammation resulting from obesity is considered dangerous and leaves many confused about whether this actually ...

Jessie J, who shared her breast cancer diagnosis in June and underwent surgery this summer, said she's been "crying a lot" as ...

Electronic data capture (EDC) extract from the ongoing ACR-368 registrational-intent Phase 2b monotherapy trial in OncoSignature-positive (BM+) subjects with endometrial cancer (EC) showed 39% overall ...